GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Smarcc1
|
ENSRNOG00000020804 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
Fosl1
|
ENSRNOG00000020552 | FOS like 1, AP-1 transcription factor subunit |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Fosl1 | rn6_v1_chr1_+_220826560_220826560 | -0.51 | 3.3e-22 | Click! |
Smarcc1 | rn6_v1_chr8_+_118206698_118206703 | -0.13 | 1.9e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_98370797 | 82.40 |
ENSRNOT00000031991
|
AABR07060872.1
|
|
chr3_+_16753703 | 58.75 |
ENSRNOT00000077741
|
AABR07051548.2
|
|
chr3_+_19274273 | 54.44 |
ENSRNOT00000040102
|
AABR07051684.1
|
|
chr1_-_197821936 | 54.27 |
ENSRNOT00000055027
|
Cd19
|
CD19 molecule |
chr6_-_138508753 | 50.85 |
ENSRNOT00000006888
|
Ighm
|
immunoglobulin heavy constant mu |
chr1_+_215666628 | 50.55 |
ENSRNOT00000040598
ENSRNOT00000066135 ENSRNOT00000051425 ENSRNOT00000080339 ENSRNOT00000066896 ENSRNOT00000063918 |
Tnnt3
|
troponin T3, fast skeletal type |
chr4_+_98457810 | 49.42 |
ENSRNOT00000074175
|
AABR07060872.1
|
|
chr4_+_70828894 | 47.90 |
ENSRNOT00000064892
|
Trbc2
|
T cell receptor beta, constant 2 |
chr4_-_155401480 | 46.87 |
ENSRNOT00000020735
|
Apobec1
|
apolipoprotein B mRNA editing enzyme catalytic subunit 1 |
chr20_-_4132604 | 46.34 |
ENSRNOT00000077630
ENSRNOT00000048332 |
RT1-Da
|
RT1 class II, locus Da |
chr12_+_25498198 | 44.24 |
ENSRNOT00000076916
|
Ncf1
|
neutrophil cytosolic factor 1 |
chr4_+_78694447 | 43.51 |
ENSRNOT00000011945
|
Gpnmb
|
glycoprotein nmb |
chr18_-_28438654 | 43.30 |
ENSRNOT00000036301
|
Mzb1
|
marginal zone B and B1 cell-specific protein |
chr20_+_4043741 | 42.86 |
ENSRNOT00000000525
|
RT1-Bb
|
RT1 class II, locus Bb |
chr4_-_103761881 | 42.65 |
ENSRNOT00000084103
|
AABR07061087.1
|
|
chr1_+_199555722 | 42.51 |
ENSRNOT00000054983
|
Itgax
|
integrin subunit alpha X |
chr3_+_16610086 | 41.70 |
ENSRNOT00000046231
|
LOC100361009
|
rCG64257-like |
chr2_-_227207584 | 41.20 |
ENSRNOT00000065361
ENSRNOT00000080215 |
Myoz2
|
myozenin 2 |
chr11_+_85430400 | 40.86 |
ENSRNOT00000083198
|
AABR07034729.1
|
|
chr3_+_19772056 | 40.24 |
ENSRNOT00000044455
|
AABR07051708.1
|
|
chr6_-_138249382 | 40.14 |
ENSRNOT00000085678
ENSRNOT00000006912 |
Ighm
|
immunoglobulin heavy constant mu |
chr3_+_18706988 | 39.44 |
ENSRNOT00000074650
|
AABR07051652.1
|
|
chr10_-_87067456 | 39.39 |
ENSRNOT00000014163
|
Ccr7
|
C-C motif chemokine receptor 7 |
chr1_+_140601791 | 38.24 |
ENSRNOT00000091588
|
Isg20
|
interferon stimulated exonuclease gene 20 |
chr19_-_10681145 | 38.13 |
ENSRNOT00000022167
|
Ccl22
|
C-C motif chemokine ligand 22 |
chr6_+_137184820 | 37.84 |
ENSRNOT00000073796
|
Adssl1
|
adenylosuccinate synthase like 1 |
chr15_-_35417273 | 37.79 |
ENSRNOT00000083961
ENSRNOT00000041430 |
Gzmb
|
granzyme B |
chr3_+_171037957 | 37.50 |
ENSRNOT00000008764
|
Rbm38
|
RNA binding motif protein 38 |
chr10_-_88152064 | 37.30 |
ENSRNOT00000019477
|
Krt16
|
keratin 16 |
chr3_+_20303979 | 36.42 |
ENSRNOT00000058331
|
AABR07051730.1
|
|
chr4_+_102262007 | 36.37 |
ENSRNOT00000079328
|
AABR07060992.2
|
|
chr1_-_198486157 | 36.37 |
ENSRNOT00000022758
|
Zg16
|
zymogen granule protein 16 |
chr4_+_102147211 | 35.44 |
ENSRNOT00000083239
|
AABR07060980.1
|
|
chr4_+_69295641 | 35.41 |
ENSRNOT00000079683
|
Trbv5
|
T cell receptor beta, variable 5 |
chr16_+_75572070 | 34.86 |
ENSRNOT00000043486
|
Defb52
|
defensin beta 52 |
chr13_-_90839411 | 34.72 |
ENSRNOT00000010594
|
Slamf9
|
SLAM family member 9 |
chr14_+_21177237 | 33.78 |
ENSRNOT00000004866
|
Jchain
|
immunoglobulin joining chain |
chr10_+_70411738 | 33.41 |
ENSRNOT00000078046
|
Slfn4
|
schlafen 4 |
chr12_+_24761210 | 33.26 |
ENSRNOT00000002003
|
Cldn4
|
claudin 4 |
chr3_+_20641664 | 33.22 |
ENSRNOT00000044699
|
AABR07051741.1
|
|
chr14_+_44889287 | 32.90 |
ENSRNOT00000091312
ENSRNOT00000032273 |
Tmem156
|
transmembrane protein 156 |
chr11_-_60547201 | 32.62 |
ENSRNOT00000093151
|
Btla
|
B and T lymphocyte associated |
chr13_+_27889345 | 32.46 |
ENSRNOT00000079134
ENSRNOT00000003274 |
Serpinb8
|
serpin family B member 8 |
chr13_+_50164563 | 32.34 |
ENSRNOT00000029533
|
Lax1
|
lymphocyte transmembrane adaptor 1 |
chr10_-_19574094 | 32.32 |
ENSRNOT00000059810
|
Dock2
|
dedicator of cytokinesis 2 |
chr6_-_138852571 | 32.31 |
ENSRNOT00000081803
|
AABR07065656.8
|
|
chr1_-_14412807 | 32.14 |
ENSRNOT00000074583
|
Tnfaip3
|
TNF alpha induced protein 3 |
chr7_-_12741296 | 32.09 |
ENSRNOT00000060648
|
Arhgap45
|
Rho GTPase activating protein 45 |
chr15_-_34647421 | 32.02 |
ENSRNOT00000072426
|
Mcpt8
|
mast cell protease 8 |
chr3_+_18970574 | 31.80 |
ENSRNOT00000088394
|
AABR07051665.1
|
|
chr11_+_27364916 | 31.60 |
ENSRNOT00000002151
|
Bach1
|
BTB domain and CNC homolog 1 |
chr3_-_105512939 | 31.54 |
ENSRNOT00000011773
|
Actc1
|
actin, alpha, cardiac muscle 1 |
chr17_-_70548071 | 31.39 |
ENSRNOT00000073144
|
Il2ra
|
interleukin 2 receptor subunit alpha |
chr9_-_14706557 | 30.76 |
ENSRNOT00000048975
|
Treml4
|
triggering receptor expressed on myeloid cells-like 4 |
chr1_-_145870912 | 30.64 |
ENSRNOT00000016289
|
Il16
|
interleukin 16 |
chr1_-_227441442 | 30.62 |
ENSRNOT00000028433
|
Ms4a1
|
membrane spanning 4-domains A1 |
chr1_+_199596024 | 30.45 |
ENSRNOT00000085336
|
Itgad
|
integrin subunit alpha D |
chr1_+_81499821 | 30.09 |
ENSRNOT00000027100
|
Lypd3
|
Ly6/Plaur domain containing 3 |
chr4_-_157252565 | 30.05 |
ENSRNOT00000079947
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr5_+_164796185 | 30.00 |
ENSRNOT00000010779
|
Nppb
|
natriuretic peptide B |
chr15_-_36472327 | 29.89 |
ENSRNOT00000032601
ENSRNOT00000059660 |
LOC102553861
|
granzyme-like protein 1-like |
chr8_+_55603968 | 29.87 |
ENSRNOT00000066848
|
Pou2af1
|
POU class 2 associating factor 1 |
chr15_-_36114752 | 29.82 |
ENSRNOT00000045209
|
Gzmbl3
|
Granzyme B-like 3 |
chr4_+_98371184 | 29.63 |
ENSRNOT00000086911
|
AABR07060872.1
|
|
chr3_+_18315320 | 29.59 |
ENSRNOT00000006954
|
AABR07051626.2
|
|
chr13_-_91981432 | 29.38 |
ENSRNOT00000004637
|
AABR07021804.1
|
|
chr4_+_102876038 | 29.30 |
ENSRNOT00000085205
|
AABR07061022.3
|
|
chr20_+_3230052 | 28.48 |
ENSRNOT00000078454
|
RT1-T24-3
|
RT1 class I, locus T24, gene 3 |
chr11_-_60546997 | 28.38 |
ENSRNOT00000083124
ENSRNOT00000050092 |
Btla
|
B and T lymphocyte associated |
chr2_-_197814808 | 28.28 |
ENSRNOT00000074156
|
Adamtsl4
|
ADAMTS-like 4 |
chr17_-_43626538 | 28.07 |
ENSRNOT00000074292
|
Hist2h3c2
|
histone cluster 2, H3c2 |
chr18_-_55859333 | 28.06 |
ENSRNOT00000025989
|
Myoz3
|
myozenin 3 |
chr11_-_66759402 | 27.79 |
ENSRNOT00000003326
|
Hcls1
|
hematopoietic cell specific Lyn substrate 1 |
chr7_+_11077411 | 27.77 |
ENSRNOT00000007117
|
S1pr4
|
sphingosine-1-phosphate receptor 4 |
chr3_-_91217491 | 27.13 |
ENSRNOT00000006115
|
Rag1
|
recombination activating 1 |
chr10_+_70417108 | 26.97 |
ENSRNOT00000079325
|
Slfn4
|
schlafen 4 |
chr4_+_93888502 | 26.77 |
ENSRNOT00000090783
|
AABR07060792.1
|
|
chr11_+_54619129 | 26.19 |
ENSRNOT00000059924
|
Trat1
|
T cell receptor associated transmembrane adaptor 1 |
chr6_-_143590448 | 25.87 |
ENSRNOT00000056771
|
Ighv8-4
|
immunoglobulin heavy variable V8-4 |
chr10_+_53740841 | 25.79 |
ENSRNOT00000004295
|
Myh2
|
myosin heavy chain 2 |
chr19_+_50045020 | 25.57 |
ENSRNOT00000090165
|
Plcg2
|
phospholipase C, gamma 2 |
chr3_+_16590244 | 25.52 |
ENSRNOT00000073229
|
AABR07051535.1
|
|
chr15_+_31417147 | 25.32 |
ENSRNOT00000092182
|
AABR07017824.2
|
|
chr8_+_41657566 | 25.16 |
ENSRNOT00000042860
|
Rup2
|
urinary protein 2 |
chr10_-_56270640 | 25.08 |
ENSRNOT00000056918
|
Cd68
|
Cd68 molecule |
chr14_-_86796378 | 24.93 |
ENSRNOT00000092021
|
Myo1g
|
myosin IG |
chr5_+_164808323 | 24.90 |
ENSRNOT00000011005
|
Nppa
|
natriuretic peptide A |
chr10_+_47412582 | 24.75 |
ENSRNOT00000003139
|
Tnfrsf13b
|
TNF receptor superfamily member 13B |
chr3_+_114355798 | 24.74 |
ENSRNOT00000024658
ENSRNOT00000036435 |
Slc28a2
|
solute carrier family 28 member 2 |
chr14_+_91782354 | 24.57 |
ENSRNOT00000005902
|
Ikzf1
|
IKAROS family zinc finger 1 |
chr6_-_138679665 | 24.55 |
ENSRNOT00000086777
|
AABR07065651.4
|
|
chr7_-_143317674 | 24.53 |
ENSRNOT00000080010
|
Krt5
|
keratin 5 |
chr2_+_183674522 | 24.43 |
ENSRNOT00000014433
|
Tmem154
|
transmembrane protein 154 |
chr6_-_138093643 | 24.37 |
ENSRNOT00000045874
|
Igh-6
|
immunoglobulin heavy chain 6 |
chr4_+_99185885 | 24.20 |
ENSRNOT00000009392
|
Cd8b
|
CD8b molecule |
chr15_-_34693034 | 24.15 |
ENSRNOT00000083314
|
Mcpt8
|
mast cell protease 8 |
chr4_+_14071507 | 23.99 |
ENSRNOT00000066224
ENSRNOT00000075962 |
Cd36
RGD1565355
|
CD36 molecule similar to fatty acid translocase/CD36 |
chr1_-_213907144 | 23.74 |
ENSRNOT00000054874
|
Sigirr
|
single Ig and TIR domain containing |
chr4_-_157252104 | 23.65 |
ENSRNOT00000082739
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr10_-_34242985 | 23.24 |
ENSRNOT00000046438
|
RGD1559575
|
similar to novel protein |
chr8_+_5606592 | 22.91 |
ENSRNOT00000011727
|
Mmp12
|
matrix metallopeptidase 12 |
chr5_+_79179417 | 22.67 |
ENSRNOT00000010454
|
Orm1
|
orosomucoid 1 |
chr4_+_78513459 | 22.57 |
ENSRNOT00000082905
|
Aoc1
|
amine oxidase, copper containing 1 |
chr4_+_3043231 | 22.49 |
ENSRNOT00000013732
|
Il6
|
interleukin 6 |
chr3_+_16846412 | 22.48 |
ENSRNOT00000074266
|
AABR07051551.1
|
|
chr3_+_17889972 | 22.47 |
ENSRNOT00000073021
|
AABR07051611.1
|
|
chr7_+_118692851 | 22.45 |
ENSRNOT00000091911
|
LOC100911562
|
apolipoprotein L3-like |
chr6_-_127337791 | 22.25 |
ENSRNOT00000032015
|
Ifi27l2b
|
interferon, alpha-inducible protein 27 like 2B |
chr13_+_26903052 | 22.24 |
ENSRNOT00000003625
|
Serpinb5
|
serpin family B member 5 |
chr8_+_117117430 | 22.20 |
ENSRNOT00000073247
|
Gpx1
|
glutathione peroxidase 1 |
chr17_-_31706523 | 22.10 |
ENSRNOT00000071312
|
AABR07027447.1
|
|
chr6_-_138679506 | 22.00 |
ENSRNOT00000075376
|
AABR07065651.4
|
|
chr18_-_6587080 | 21.70 |
ENSRNOT00000040815
|
LOC103694404
|
60S ribosomal protein L39 |
chr15_+_29208606 | 21.65 |
ENSRNOT00000073722
ENSRNOT00000086054 |
LOC100911980
|
uncharacterized LOC100911980 |
chr1_+_81230612 | 21.64 |
ENSRNOT00000026489
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4 |
chr1_+_81230989 | 21.63 |
ENSRNOT00000077952
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4 |
chr4_+_102068556 | 21.58 |
ENSRNOT00000077412
|
AABR07060971.1
|
|
chr3_-_121882726 | 21.54 |
ENSRNOT00000006308
|
Il1b
|
interleukin 1 beta |
chr6_-_138536162 | 21.51 |
ENSRNOT00000083031
|
AABR07065643.1
|
|
chr10_+_83655460 | 21.48 |
ENSRNOT00000008011
|
Gngt2
|
G protein subunit gamma transducin 2 |
chr16_-_56900052 | 21.46 |
ENSRNOT00000017339
|
Msr1
|
macrophage scavenger receptor 1 |
chr1_-_226791773 | 21.43 |
ENSRNOT00000082482
ENSRNOT00000065376 ENSRNOT00000054812 ENSRNOT00000086669 |
LOC100911215
|
T-cell surface glycoprotein CD5-like |
chr2_-_45518502 | 21.33 |
ENSRNOT00000014627
|
Hspb3
|
heat shock protein family B (small) member 3 |
chr12_+_20667601 | 21.20 |
ENSRNOT00000090081
|
RGD1560281
|
similar to cell surface receptor FDFACT |
chr20_+_4039413 | 21.11 |
ENSRNOT00000082136
|
RT1-Bb
|
RT1 class II, locus Bb |
chr3_+_16413080 | 21.10 |
ENSRNOT00000040386
|
LOC100912707
|
Ig kappa chain V19-17-like |
chr9_-_43116521 | 21.02 |
ENSRNOT00000039437
|
Ankrd23
|
ankyrin repeat domain 23 |
chr17_+_10138810 | 20.90 |
ENSRNOT00000079850
|
Hk3
|
hexokinase 3 |
chr7_+_116632506 | 20.74 |
ENSRNOT00000009811
|
Gpihbp1
|
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 |
chr2_-_189254628 | 20.56 |
ENSRNOT00000028234
|
Il6r
|
interleukin 6 receptor |
chr13_-_36101411 | 20.42 |
ENSRNOT00000074471
|
Tmem37
|
transmembrane protein 37 |
chr3_-_17081510 | 20.41 |
ENSRNOT00000063862
|
AABR07051562.1
|
|
chr3_-_16999720 | 20.37 |
ENSRNOT00000074382
|
RGD1563231
|
similar to immunoglobulin kappa-chain VK-1 |
chr5_-_155772040 | 20.33 |
ENSRNOT00000036788
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr4_-_23135354 | 20.25 |
ENSRNOT00000011432
|
Steap4
|
STEAP4 metalloreductase |
chr1_+_266053002 | 20.24 |
ENSRNOT00000026235
|
Nfkb2
|
nuclear factor kappa B subunit 2 |
chr6_-_142372031 | 20.22 |
ENSRNOT00000063929
|
AABR07065814.3
|
|
chr16_-_9430743 | 20.18 |
ENSRNOT00000043811
|
Wdfy4
|
WDFY family member 4 |
chr8_-_128711221 | 20.07 |
ENSRNOT00000055888
|
Xirp1
|
xin actin-binding repeat containing 1 |
chr3_+_16817051 | 19.95 |
ENSRNOT00000071666
|
AABR07051550.1
|
|
chr18_+_3861539 | 19.69 |
ENSRNOT00000015363
|
Lama3
|
laminin subunit alpha 3 |
chr18_+_55666027 | 19.67 |
ENSRNOT00000045950
|
RGD1305184
|
similar to CDNA sequence BC023105 |
chr3_+_17546566 | 19.63 |
ENSRNOT00000050825
|
AABR07051583.1
|
|
chr4_+_99168248 | 19.60 |
ENSRNOT00000058186
|
LOC102552663
|
uncharacterized LOC102552663 |
chr2_-_216348194 | 19.59 |
ENSRNOT00000087839
|
LOC103689940
|
pancreatic alpha-amylase-like |
chr15_+_32355565 | 19.33 |
ENSRNOT00000072382
|
AABR07017900.1
|
|
chr14_-_86047162 | 19.33 |
ENSRNOT00000018227
|
Pgam2
|
phosphoglycerate mutase 2 |
chr7_-_143863186 | 19.32 |
ENSRNOT00000017096
|
Rarg
|
retinoic acid receptor, gamma |
chr1_+_220992770 | 19.32 |
ENSRNOT00000045233
|
Rela
|
RELA proto-oncogene, NF-kB subunit |
chr5_+_61425746 | 19.31 |
ENSRNOT00000064113
|
RGD1305807
|
hypothetical LOC298077 |
chr4_+_162392869 | 19.15 |
ENSRNOT00000047790
|
Clec2d
|
C-type lectin domain family 2, member D |
chr16_+_29674793 | 19.04 |
ENSRNOT00000059724
|
Anxa10
|
annexin A10 |
chr8_+_52751854 | 18.92 |
ENSRNOT00000072518
|
Nxpe1
|
neurexophilin and PC-esterase domain family, member 1 |
chr15_-_29761117 | 18.82 |
ENSRNOT00000075194
|
AABR07017658.2
|
|
chr3_-_172537877 | 18.82 |
ENSRNOT00000072069
|
Ctsz
|
cathepsin Z |
chr20_+_30791422 | 18.78 |
ENSRNOT00000047394
ENSRNOT00000000683 |
Tbata
|
thymus, brain and testes associated |
chr15_-_34694180 | 18.69 |
ENSRNOT00000079505
ENSRNOT00000027950 ENSRNOT00000079782 ENSRNOT00000080221 |
Mcpt8
|
mast cell protease 8 |
chr3_-_113405829 | 18.68 |
ENSRNOT00000036823
|
Ell3
|
elongation factor for RNA polymerase II 3 |
chr18_-_28535828 | 18.59 |
ENSRNOT00000068386
|
Tmem173
|
transmembrane protein 173 |
chr4_+_103495993 | 18.56 |
ENSRNOT00000072325
|
AABR07061068.1
|
|
chr14_+_76732650 | 18.47 |
ENSRNOT00000088197
|
Clnk
|
cytokine-dependent hematopoietic cell linker |
chr15_-_45524582 | 18.41 |
ENSRNOT00000081912
|
Gucy1b2
|
guanylate cyclase 1 soluble subunit beta 2 |
chr10_-_106976040 | 18.37 |
ENSRNOT00000003940
|
Socs3
|
suppressor of cytokine signaling 3 |
chr10_+_105499569 | 18.26 |
ENSRNOT00000088457
|
Sphk1
|
sphingosine kinase 1 |
chr15_-_45545875 | 18.21 |
ENSRNOT00000087678
|
Gucy1b2
|
guanylate cyclase 1 soluble subunit beta 2 |
chr4_+_69386698 | 18.21 |
ENSRNOT00000091655
|
Trbv13-2
|
T cell receptor beta, variable 13-2 |
chr6_-_138909105 | 18.12 |
ENSRNOT00000087855
|
AABR07065656.9
|
|
chr10_-_110232843 | 18.02 |
ENSRNOT00000054934
|
Cd7
|
Cd7 molecule |
chr13_-_90074952 | 17.97 |
ENSRNOT00000038006
|
Slamf7
|
SLAM family member 7 |
chr13_+_47572219 | 17.94 |
ENSRNOT00000088449
ENSRNOT00000087664 ENSRNOT00000005853 |
Pigr
|
polymeric immunoglobulin receptor |
chr3_-_110517163 | 17.67 |
ENSRNOT00000078037
|
Plcb2
|
phospholipase C, beta 2 |
chr1_-_42971208 | 17.28 |
ENSRNOT00000088535
|
Gm5414
|
predicted gene 5414 |
chr20_-_4677034 | 17.15 |
ENSRNOT00000075244
|
Rn60_20_0047.3
|
|
chr17_-_32783427 | 17.13 |
ENSRNOT00000059921
|
Serpinb6b
|
serine (or cysteine) peptidase inhibitor, clade B, member 6b |
chr15_-_29443454 | 17.11 |
ENSRNOT00000082167
|
AABR07017635.2
|
|
chr3_+_1478525 | 17.07 |
ENSRNOT00000008161
|
Psd4
|
pleckstrin and Sec7 domain containing 4 |
chr13_+_92264231 | 17.04 |
ENSRNOT00000066509
ENSRNOT00000004716 |
Spta1
|
spectrin, alpha, erythrocytic 1 |
chr13_+_27465930 | 16.97 |
ENSRNOT00000003314
|
Serpinb10
|
serpin family B member 10 |
chr1_+_151918571 | 16.94 |
ENSRNOT00000022342
|
Ctsc
|
cathepsin C |
chr10_-_88122233 | 16.85 |
ENSRNOT00000083895
ENSRNOT00000005285 |
Krt14
|
keratin 14 |
chr3_-_16441030 | 16.82 |
ENSRNOT00000047784
|
AABR07051532.1
|
|
chr7_-_12634641 | 16.75 |
ENSRNOT00000093132
|
Cfd
|
complement factor D |
chr3_-_14019204 | 16.73 |
ENSRNOT00000072400
ENSRNOT00000092918 |
Traf1
|
TNF receptor-associated factor 1 |
chr7_-_18793289 | 16.64 |
ENSRNOT00000036375
|
AABR07056026.1
|
|
chr6_-_140215907 | 16.63 |
ENSRNOT00000086370
|
AABR07065750.1
|
|
chr10_+_54352270 | 16.58 |
ENSRNOT00000036752
|
Dhrs7c
|
dehydrogenase/reductase 7C |
chrX_+_96991658 | 16.58 |
ENSRNOT00000049969
|
AABR07040288.1
|
|
chr1_-_101514547 | 16.58 |
ENSRNOT00000079633
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A |
chr4_-_170912629 | 16.57 |
ENSRNOT00000055691
|
Erp27
|
endoplasmic reticulum protein 27 |
chr18_+_56414488 | 16.54 |
ENSRNOT00000088988
|
Csf1r
|
colony stimulating factor 1 receptor |
chr10_+_92667869 | 16.51 |
ENSRNOT00000082780
ENSRNOT00000073350 |
Itgb3
|
integrin subunit beta 3 |
chr11_-_60819249 | 16.50 |
ENSRNOT00000043917
ENSRNOT00000042447 |
Cd200r1l
|
CD200 receptor 1-like |
chr6_+_127927650 | 16.48 |
ENSRNOT00000057271
|
LOC100909605
|
serine protease inhibitor A3F-like |
chr15_+_31950986 | 16.43 |
ENSRNOT00000080233
|
AABR07017868.4
|
|
chr3_-_16753987 | 16.43 |
ENSRNOT00000091257
|
AABR07051548.1
|
|
chr10_-_86509454 | 16.43 |
ENSRNOT00000009454
|
Ikzf3
|
IKAROS family zinc finger 3 |
chr15_+_36898195 | 16.36 |
ENSRNOT00000076266
|
Parp4
|
poly (ADP-ribose) polymerase family, member 4 |
chr7_+_118685022 | 16.33 |
ENSRNOT00000089135
|
Apol3
|
apolipoprotein L, 3 |
chr6_-_142933110 | 16.32 |
ENSRNOT00000046885
|
AABR07065823.1
|
|
chr4_+_93791054 | 16.22 |
ENSRNOT00000042300
|
AABR07060788.1
|
|
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
20.8 | 62.3 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
18.5 | 92.6 | GO:0009608 | response to symbiont(GO:0009608) |
17.9 | 53.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
17.8 | 53.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
16.8 | 50.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
16.2 | 48.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
12.8 | 51.0 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
12.6 | 37.8 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
12.6 | 37.8 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
12.3 | 61.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
11.3 | 45.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
10.8 | 43.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
10.8 | 32.3 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
9.4 | 28.3 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
9.4 | 56.5 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
9.4 | 37.4 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
8.9 | 88.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
8.5 | 25.4 | GO:0060101 | negative regulation of phagocytosis, engulfment(GO:0060101) |
8.2 | 8.2 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
8.1 | 24.4 | GO:0046864 | isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
7.9 | 31.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
7.8 | 31.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
7.6 | 22.9 | GO:1902739 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
7.6 | 22.8 | GO:0072703 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) response to methyl methanesulfonate(GO:0072702) cellular response to methyl methanesulfonate(GO:0072703) positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
7.5 | 74.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
7.2 | 21.7 | GO:0035995 | detection of muscle stretch(GO:0035995) regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
7.2 | 14.4 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
7.2 | 21.5 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
6.9 | 27.8 | GO:0042531 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
6.9 | 20.7 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
6.9 | 20.6 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
6.8 | 40.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
6.8 | 27.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
6.7 | 20.0 | GO:0003192 | mitral valve formation(GO:0003192) |
6.4 | 19.3 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) negative regulation of adipose tissue development(GO:1904178) |
6.4 | 19.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
6.3 | 12.7 | GO:0071661 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
5.8 | 34.8 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
5.8 | 69.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
5.8 | 28.8 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
5.7 | 68.7 | GO:0006968 | cellular defense response(GO:0006968) |
5.7 | 28.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
5.6 | 33.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
5.5 | 16.5 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) regulation of opioid receptor signaling pathway(GO:2000474) |
5.4 | 27.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
5.4 | 16.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
5.3 | 15.9 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
5.3 | 15.8 | GO:2000502 | immune complex clearance(GO:0002434) T cell extravasation(GO:0072683) negative regulation of natural killer cell chemotaxis(GO:2000502) |
5.0 | 45.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
5.0 | 30.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
4.8 | 9.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
4.8 | 24.0 | GO:0072564 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
4.7 | 14.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
4.6 | 9.2 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) |
4.5 | 18.1 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
4.5 | 13.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
4.5 | 13.4 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
4.4 | 8.7 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
4.2 | 12.7 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
4.2 | 12.5 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
4.2 | 20.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
4.1 | 24.7 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
4.1 | 12.2 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
4.0 | 28.2 | GO:0070269 | pyroptosis(GO:0070269) |
4.0 | 12.0 | GO:1902595 | DNA replication preinitiation complex assembly(GO:0071163) regulation of DNA replication origin binding(GO:1902595) |
3.9 | 11.6 | GO:1990743 | protein sialylation(GO:1990743) |
3.8 | 15.2 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
3.8 | 22.7 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
3.8 | 15.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
3.7 | 3.7 | GO:0019483 | beta-alanine biosynthetic process(GO:0019483) |
3.7 | 11.2 | GO:1902988 | regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
3.7 | 18.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
3.6 | 14.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
3.6 | 28.6 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
3.6 | 10.7 | GO:0000053 | argininosuccinate metabolic process(GO:0000053) |
3.6 | 24.9 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
3.5 | 10.6 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
3.5 | 10.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
3.5 | 41.8 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
3.4 | 10.3 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
3.4 | 3.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
3.4 | 10.3 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
3.4 | 6.8 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
3.4 | 53.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
3.3 | 3.3 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
3.3 | 19.5 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
3.2 | 16.2 | GO:0010037 | response to carbon dioxide(GO:0010037) |
3.2 | 116.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
3.2 | 9.6 | GO:0051977 | lysophospholipid transport(GO:0051977) |
3.2 | 9.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
3.2 | 66.7 | GO:0031424 | keratinization(GO:0031424) |
3.1 | 9.4 | GO:1903769 | negative regulation of cell proliferation in bone marrow(GO:1903769) |
3.1 | 18.8 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
3.1 | 9.4 | GO:0046724 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) oxalic acid secretion(GO:0046724) |
3.1 | 12.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
3.0 | 12.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
3.0 | 30.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
3.0 | 6.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
3.0 | 12.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
3.0 | 12.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
3.0 | 12.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
2.9 | 20.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
2.9 | 29.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
2.9 | 17.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.8 | 11.4 | GO:0071283 | cellular response to iron(III) ion(GO:0071283) |
2.8 | 11.3 | GO:1904975 | response to bleomycin(GO:1904975) |
2.8 | 25.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
2.8 | 2.8 | GO:0043366 | beta selection(GO:0043366) |
2.8 | 11.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
2.8 | 11.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.8 | 8.4 | GO:0001805 | antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
2.8 | 8.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
2.8 | 2.8 | GO:0003162 | atrioventricular node development(GO:0003162) |
2.7 | 16.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
2.7 | 10.8 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
2.7 | 16.1 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
2.7 | 8.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
2.7 | 10.7 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
2.7 | 8.0 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.7 | 10.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
2.7 | 21.3 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
2.6 | 21.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
2.6 | 10.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.6 | 5.2 | GO:0045425 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
2.6 | 7.7 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
2.5 | 2.5 | GO:0071724 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
2.5 | 7.4 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
2.4 | 12.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
2.4 | 12.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
2.4 | 4.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
2.4 | 9.6 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
2.4 | 2.4 | GO:0006212 | uracil catabolic process(GO:0006212) |
2.4 | 14.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
2.4 | 2.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
2.4 | 21.5 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
2.4 | 14.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
2.4 | 25.9 | GO:0002467 | germinal center formation(GO:0002467) |
2.4 | 11.8 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
2.3 | 11.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
2.3 | 18.7 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
2.3 | 28.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
2.3 | 7.0 | GO:1904585 | positive regulation of B cell apoptotic process(GO:0002904) canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) |
2.3 | 9.3 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
2.3 | 13.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
2.3 | 13.7 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
2.3 | 9.2 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
2.3 | 16.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
2.3 | 6.8 | GO:0014739 | positive regulation of muscle hyperplasia(GO:0014739) |
2.3 | 11.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
2.2 | 6.7 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
2.2 | 9.0 | GO:0071640 | regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
2.2 | 8.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
2.2 | 6.6 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
2.2 | 6.6 | GO:0090131 | mesenchyme migration(GO:0090131) |
2.2 | 87.2 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
2.2 | 15.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
2.1 | 17.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
2.1 | 6.4 | GO:0021539 | subthalamus development(GO:0021539) |
2.1 | 8.5 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
2.1 | 14.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
2.1 | 6.3 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
2.1 | 6.3 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
2.1 | 2.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
2.1 | 14.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
2.1 | 8.2 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
2.0 | 4.1 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
2.0 | 4.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
2.0 | 30.4 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
2.0 | 6.1 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
2.0 | 6.0 | GO:0044726 | protection of DNA demethylation of female pronucleus(GO:0044726) |
2.0 | 12.0 | GO:0051132 | NK T cell activation(GO:0051132) |
2.0 | 6.0 | GO:0060764 | cell-cell signaling involved in mammary gland development(GO:0060764) |
2.0 | 7.9 | GO:1900158 | positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
2.0 | 15.8 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
1.9 | 15.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.9 | 81.3 | GO:0006956 | complement activation(GO:0006956) |
1.9 | 9.6 | GO:0050828 | regulation of liquid surface tension(GO:0050828) |
1.9 | 15.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.9 | 15.4 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
1.9 | 30.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.9 | 11.4 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
1.9 | 9.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.9 | 16.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.9 | 44.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
1.9 | 7.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.9 | 5.6 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
1.9 | 11.2 | GO:0000255 | allantoin metabolic process(GO:0000255) isoleucine metabolic process(GO:0006549) |
1.9 | 3.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.9 | 27.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.9 | 7.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.8 | 5.5 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.8 | 7.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.8 | 11.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.8 | 53.2 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
1.8 | 7.3 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
1.8 | 3.7 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
1.8 | 43.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
1.8 | 7.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.8 | 20.0 | GO:0002934 | desmosome organization(GO:0002934) |
1.8 | 91.8 | GO:0030239 | myofibril assembly(GO:0030239) |
1.8 | 32.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
1.8 | 5.3 | GO:1905133 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
1.8 | 5.3 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
1.8 | 3.5 | GO:0010935 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
1.8 | 5.3 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
1.7 | 8.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.7 | 10.3 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
1.7 | 32.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.7 | 3.4 | GO:0032701 | negative regulation of interleukin-18 production(GO:0032701) |
1.7 | 8.5 | GO:0000019 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
1.7 | 6.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.7 | 5.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.7 | 5.0 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
1.7 | 3.3 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
1.7 | 11.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
1.6 | 8.2 | GO:0071104 | response to interleukin-9(GO:0071104) |
1.6 | 8.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.6 | 4.9 | GO:0033986 | response to methanol(GO:0033986) |
1.6 | 4.9 | GO:0042701 | progesterone secretion(GO:0042701) |
1.6 | 6.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.6 | 4.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.6 | 8.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
1.6 | 4.8 | GO:0080144 | amino acid homeostasis(GO:0080144) |
1.6 | 22.4 | GO:0071280 | cellular response to copper ion(GO:0071280) |
1.6 | 6.4 | GO:1902336 | positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
1.6 | 12.7 | GO:0050718 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
1.6 | 4.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
1.6 | 7.8 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
1.6 | 9.3 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
1.5 | 12.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
1.5 | 6.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.5 | 9.2 | GO:1900225 | NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
1.5 | 15.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.5 | 9.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.5 | 7.6 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
1.5 | 12.1 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.5 | 6.1 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
1.5 | 10.5 | GO:0007144 | female meiosis I(GO:0007144) |
1.5 | 9.0 | GO:0015074 | DNA integration(GO:0015074) |
1.5 | 8.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.5 | 7.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.5 | 11.8 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
1.5 | 20.6 | GO:0032060 | bleb assembly(GO:0032060) |
1.5 | 8.8 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.5 | 5.9 | GO:0033131 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
1.5 | 10.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
1.5 | 7.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.4 | 5.8 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.4 | 10.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.4 | 5.6 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
1.4 | 21.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.4 | 37.8 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.4 | 4.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.4 | 11.1 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
1.4 | 6.9 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.4 | 6.9 | GO:1903659 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) |
1.4 | 13.8 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
1.4 | 4.1 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
1.4 | 13.8 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.4 | 6.9 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.4 | 8.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.4 | 19.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
1.4 | 2.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.4 | 4.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
1.4 | 14.9 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
1.4 | 6.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.3 | 48.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
1.3 | 2.6 | GO:0042335 | cuticle development(GO:0042335) |
1.3 | 19.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
1.3 | 10.5 | GO:0048102 | autophagic cell death(GO:0048102) |
1.3 | 9.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.3 | 5.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.3 | 3.9 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
1.3 | 3.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
1.3 | 3.8 | GO:0051012 | microtubule sliding(GO:0051012) |
1.3 | 7.7 | GO:0042730 | fibrinolysis(GO:0042730) |
1.3 | 5.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.3 | 2.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.3 | 17.7 | GO:0019532 | oxalate transport(GO:0019532) |
1.3 | 21.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
1.2 | 11.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
1.2 | 7.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.2 | 8.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.2 | 2.4 | GO:0097037 | heme export(GO:0097037) |
1.2 | 3.6 | GO:0097350 | neutrophil clearance(GO:0097350) |
1.2 | 6.0 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
1.2 | 4.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.2 | 16.2 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
1.2 | 12.7 | GO:0015747 | urate transport(GO:0015747) |
1.2 | 4.6 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.2 | 11.5 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
1.2 | 5.8 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
1.1 | 24.1 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
1.1 | 8.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
1.1 | 1.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
1.1 | 4.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.1 | 10.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.1 | 4.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.1 | 17.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
1.1 | 9.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.1 | 5.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.1 | 2.2 | GO:0044108 | cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
1.1 | 2.2 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
1.1 | 2.2 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
1.1 | 6.5 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
1.1 | 17.3 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
1.1 | 3.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
1.1 | 19.2 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.1 | 7.4 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.1 | 3.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.1 | 7.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.0 | 5.2 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
1.0 | 4.2 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) positive regulation of protein homooligomerization(GO:0032464) |
1.0 | 12.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
1.0 | 15.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.0 | 9.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.0 | 4.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.0 | 4.0 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.0 | 4.0 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
1.0 | 4.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.0 | 9.9 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.0 | 4.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
1.0 | 8.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.0 | 1.0 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
1.0 | 35.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
1.0 | 23.1 | GO:0050798 | activated T cell proliferation(GO:0050798) |
1.0 | 2.9 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
1.0 | 12.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.9 | 2.8 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.9 | 8.5 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.9 | 6.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.9 | 15.0 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.9 | 3.7 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.9 | 4.6 | GO:0061709 | reticulophagy(GO:0061709) |
0.9 | 27.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.9 | 11.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.9 | 3.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.9 | 3.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.9 | 2.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.9 | 3.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.9 | 2.8 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.9 | 12.8 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.9 | 16.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.9 | 7.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.9 | 0.9 | GO:0002780 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
0.9 | 5.4 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.9 | 9.8 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.9 | 4.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.9 | 3.6 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.9 | 3.5 | GO:1990375 | prostate epithelial cord elongation(GO:0060523) baculum development(GO:1990375) |
0.9 | 3.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.9 | 7.0 | GO:0032674 | regulation of interleukin-5 production(GO:0032674) |
0.9 | 6.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.9 | 15.6 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.9 | 17.2 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.9 | 6.9 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.9 | 10.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.8 | 3.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.8 | 8.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.8 | 10.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.8 | 6.6 | GO:0006068 | ethanol metabolic process(GO:0006067) ethanol catabolic process(GO:0006068) |
0.8 | 2.5 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.8 | 4.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.8 | 37.7 | GO:0048286 | lung alveolus development(GO:0048286) |
0.8 | 8.8 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.8 | 5.5 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.8 | 4.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.8 | 2.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.8 | 4.6 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.8 | 6.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.8 | 3.8 | GO:1901656 | glycoside transport(GO:1901656) |
0.8 | 7.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.8 | 7.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.8 | 2.3 | GO:1903925 | cellular response to magnetism(GO:0071259) response to bisphenol A(GO:1903925) |
0.7 | 2.2 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.7 | 3.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.7 | 1.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.7 | 3.7 | GO:0035878 | nail development(GO:0035878) |
0.7 | 5.1 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.7 | 6.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.7 | 2.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.7 | 1.5 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.7 | 0.7 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.7 | 3.6 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 3.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.7 | 2.9 | GO:0009624 | response to nematode(GO:0009624) |
0.7 | 8.0 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.7 | 2.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.7 | 3.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.7 | 2.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.7 | 5.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.7 | 7.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.7 | 6.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.7 | 3.5 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
0.7 | 9.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.7 | 0.7 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.7 | 4.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.7 | 4.2 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.7 | 3.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.7 | 2.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.7 | 2.8 | GO:1902617 | response to fluoride(GO:1902617) |
0.7 | 15.2 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.7 | 4.8 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.7 | 4.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.7 | 1.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.7 | 15.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.7 | 4.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.7 | 6.0 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.7 | 1.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.7 | 5.3 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.7 | 3.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) female courtship behavior(GO:0008050) |
0.7 | 3.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.7 | 3.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.6 | 11.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.6 | 9.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.6 | 9.0 | GO:0002076 | osteoblast development(GO:0002076) |
0.6 | 4.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 12.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.6 | 1.9 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.6 | 5.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.6 | 2.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.6 | 6.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.6 | 1.8 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.6 | 6.7 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.6 | 2.4 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.6 | 20.4 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.6 | 4.2 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.6 | 1.8 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.6 | 2.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.6 | 2.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 1.8 | GO:0021508 | floor plate formation(GO:0021508) |
0.6 | 5.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.6 | 5.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.6 | 4.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 5.7 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.6 | 5.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.6 | 31.5 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.6 | 3.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.6 | 2.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 13.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.6 | 10.5 | GO:0030903 | notochord development(GO:0030903) |
0.5 | 1.6 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.5 | 122.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.5 | 1.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.5 | 1.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.5 | 2.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.5 | 2.1 | GO:0060327 | cytoplasmic actin-based contraction involved in cell motility(GO:0060327) |
0.5 | 0.5 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.5 | 5.6 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.5 | 5.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.5 | 2.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 3.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 2.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.5 | 10.0 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.5 | 7.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.5 | 5.5 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.5 | 12.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.5 | 1.5 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.5 | 3.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.5 | 1.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 11.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 5.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 5.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.5 | 0.5 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.5 | 32.9 | GO:0006342 | chromatin silencing(GO:0006342) |
0.5 | 3.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 2.7 | GO:0098912 | membrane depolarization during bundle of His cell action potential(GO:0086048) membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.4 | 4.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.4 | 1.8 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.4 | 15.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 2.6 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.4 | 7.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.4 | 2.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 1.3 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.4 | 1.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 3.0 | GO:0007512 | adult heart development(GO:0007512) |
0.4 | 3.4 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.4 | 1.3 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.4 | 5.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 0.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 0.8 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.4 | 3.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 11.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.4 | 3.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.4 | 13.2 | GO:0060324 | face development(GO:0060324) |
0.4 | 4.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.4 | 2.0 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.4 | 1.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 2.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.4 | 1.2 | GO:0046061 | dGTP catabolic process(GO:0006203) DNA protection(GO:0042262) dATP catabolic process(GO:0046061) |
0.4 | 3.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 4.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 3.8 | GO:0097435 | fibril organization(GO:0097435) |
0.4 | 1.9 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.4 | 6.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.4 | 1.5 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.4 | 2.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.4 | 1.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 2.2 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.4 | 4.7 | GO:0070266 | necroptotic process(GO:0070266) |
0.4 | 4.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.4 | 11.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.4 | 5.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.4 | 1.1 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.4 | 1.1 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.3 | 1.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 15.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 1.0 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.3 | 0.7 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.3 | 3.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.3 | 3.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.3 | 6.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.3 | 7.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.3 | 2.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.3 | 62.8 | GO:0051604 | protein maturation(GO:0051604) |
0.3 | 6.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.3 | 1.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 3.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 4.6 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.3 | 4.0 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.3 | 1.6 | GO:0001582 | detection of chemical stimulus involved in sensory perception of sweet taste(GO:0001582) |
0.3 | 3.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 9.3 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.3 | 1.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 3.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.3 | 1.6 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.3 | 5.7 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.3 | 0.9 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.3 | 2.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 4.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 0.9 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 3.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 1.7 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.3 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.3 | 3.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 26.2 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.3 | 0.3 | GO:0044359 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 2.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.3 | 1.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 1.1 | GO:0033567 | lagging strand elongation(GO:0006273) DNA replication, Okazaki fragment processing(GO:0033567) DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 3.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 6.9 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.3 | 3.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 2.8 | GO:0060065 | uterus development(GO:0060065) |
0.3 | 1.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 4.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 2.7 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 4.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.5 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.2 | 9.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 5.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 5.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 6.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 2.6 | GO:0030168 | platelet activation(GO:0030168) |
0.2 | 2.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 2.3 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.2 | 1.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.2 | 0.9 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 1.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 2.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 3.5 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.2 | 0.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 1.1 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.2 | 1.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 2.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 3.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.2 | 2.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 2.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 0.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 1.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.6 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.2 | 4.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 0.5 | GO:0016598 | protein arginylation(GO:0016598) |
0.2 | 2.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 1.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 1.0 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.2 | 4.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.7 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 1.0 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.2 | 3.8 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 2.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.2 | GO:0060721 | regulation of spongiotrophoblast cell proliferation(GO:0060721) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.2 | 0.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 0.5 | GO:0090249 | cell motility involved in somitogenic axis elongation(GO:0090247) regulation of cell motility involved in somitogenic axis elongation(GO:0090249) |
0.2 | 0.9 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.2 | 4.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 5.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 4.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 1.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 5.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 3.6 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.4 | GO:0015791 | polyol transport(GO:0015791) glycerol transport(GO:0015793) |
0.1 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 3.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.6 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 15.5 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.4 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.1 | 1.6 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 1.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.5 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 4.7 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.5 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.9 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.3 | GO:1902416 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.1 | 1.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 2.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 1.4 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 2.7 | GO:0048599 | oocyte development(GO:0048599) |
0.1 | 134.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 1.7 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 1.5 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.1 | 1.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 2.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 2.4 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.1 | 0.8 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.2 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 0.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.7 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.3 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 3.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 3.5 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.1 | 0.7 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 1.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 2.7 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.1 | 0.6 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.6 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.9 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 1.2 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 0.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 1.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.6 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.8 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.6 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.2 | GO:1900825 | regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.9 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 1.4 | GO:0000725 | recombinational repair(GO:0000725) |
0.0 | 0.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.1 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.7 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.0 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.3 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.6 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.0 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.5 | 58.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
14.3 | 43.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
11.9 | 11.9 | GO:0061474 | phagolysosome membrane(GO:0061474) |
9.1 | 145.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
9.0 | 27.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
7.7 | 61.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
7.4 | 22.1 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
7.0 | 28.0 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
6.8 | 13.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
6.2 | 55.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
6.1 | 73.1 | GO:0005861 | troponin complex(GO:0005861) |
6.0 | 59.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
5.6 | 28.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
5.5 | 16.6 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
5.2 | 20.9 | GO:0005607 | laminin-2 complex(GO:0005607) |
5.0 | 45.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
4.7 | 37.8 | GO:0044194 | cytolytic granule(GO:0044194) |
4.6 | 23.0 | GO:0097413 | Lewy body(GO:0097413) |
4.3 | 47.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
4.1 | 12.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
4.0 | 134.5 | GO:0008305 | integrin complex(GO:0008305) |
3.9 | 15.8 | GO:0044299 | C-fiber(GO:0044299) |
3.8 | 15.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
3.7 | 14.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
3.5 | 34.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
3.3 | 19.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
3.1 | 25.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
3.1 | 21.7 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
3.1 | 9.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
3.1 | 48.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
3.0 | 45.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
2.8 | 11.3 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
2.6 | 5.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
2.5 | 9.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.5 | 9.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
2.3 | 18.3 | GO:0005638 | lamin filament(GO:0005638) |
2.3 | 15.8 | GO:0005579 | membrane attack complex(GO:0005579) |
2.2 | 11.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
2.2 | 4.4 | GO:0032994 | protein-lipid complex(GO:0032994) |
2.2 | 17.3 | GO:0097443 | sorting endosome(GO:0097443) |
2.1 | 6.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
2.0 | 148.2 | GO:0045095 | keratin filament(GO:0045095) |
1.8 | 18.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.8 | 5.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.7 | 8.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.7 | 17.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.7 | 182.2 | GO:0072562 | blood microparticle(GO:0072562) |
1.7 | 5.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.7 | 30.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
1.6 | 6.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.6 | 4.9 | GO:0043511 | inhibin complex(GO:0043511) |
1.6 | 64.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.6 | 38.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.6 | 22.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.6 | 443.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
1.5 | 6.1 | GO:0031983 | vesicle lumen(GO:0031983) |
1.5 | 7.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.5 | 17.5 | GO:0043034 | costamere(GO:0043034) |
1.4 | 5.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) IRE1-RACK1-PP2A complex(GO:1990630) |
1.4 | 11.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.4 | 5.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
1.3 | 1.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.3 | 5.3 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
1.3 | 14.3 | GO:0031143 | pseudopodium(GO:0031143) |
1.3 | 5.2 | GO:0070876 | SOSS complex(GO:0070876) |
1.3 | 9.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.3 | 29.3 | GO:0001533 | cornified envelope(GO:0001533) |
1.2 | 28.6 | GO:0001891 | phagocytic cup(GO:0001891) |
1.2 | 21.0 | GO:0030057 | desmosome(GO:0030057) |
1.2 | 6.1 | GO:0043293 | apoptosome(GO:0043293) |
1.2 | 3.6 | GO:1990423 | RZZ complex(GO:1990423) |
1.2 | 6.0 | GO:0001652 | granular component(GO:0001652) |
1.1 | 3.4 | GO:0005745 | m-AAA complex(GO:0005745) |
1.1 | 10.0 | GO:0045179 | apical cortex(GO:0045179) |
1.1 | 3.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.1 | 7.8 | GO:0005827 | polar microtubule(GO:0005827) |
1.1 | 12.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
1.1 | 6.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.1 | 12.7 | GO:0005687 | U4 snRNP(GO:0005687) |
1.0 | 23.9 | GO:0042629 | mast cell granule(GO:0042629) |
1.0 | 4.1 | GO:1990005 | granular vesicle(GO:1990005) |
1.0 | 4.1 | GO:0070552 | BRISC complex(GO:0070552) |
1.0 | 3.0 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
1.0 | 6.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.9 | 4.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.9 | 49.4 | GO:0015030 | Cajal body(GO:0015030) |
0.9 | 66.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.9 | 0.9 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.9 | 3.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.9 | 7.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.9 | 6.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.9 | 3.6 | GO:0018444 | translation release factor complex(GO:0018444) |
0.9 | 7.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.9 | 2.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 3.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.8 | 9.2 | GO:0032982 | myosin filament(GO:0032982) |
0.8 | 10.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.8 | 8.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.8 | 4.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.8 | 3.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.8 | 5.7 | GO:0000796 | condensin complex(GO:0000796) |
0.8 | 21.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.8 | 6.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.8 | 5.5 | GO:0070449 | elongin complex(GO:0070449) |
0.8 | 3.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.8 | 4.6 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.8 | 6.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.8 | 6.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.8 | 3.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.7 | 8.2 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 5.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.7 | 5.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 4.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 53.1 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.7 | 13.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.7 | 16.0 | GO:0005839 | proteasome core complex(GO:0005839) |
0.7 | 5.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 5.1 | GO:0016589 | NURF complex(GO:0016589) |
0.6 | 11.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.6 | 15.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.6 | 8.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.6 | 7.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 2.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.6 | 30.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.6 | 41.1 | GO:0000786 | nucleosome(GO:0000786) |
0.6 | 32.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.6 | 11.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.6 | 5.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.6 | 1.2 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.6 | 2.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.6 | 4.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 1.7 | GO:0005712 | chiasma(GO:0005712) |
0.5 | 13.0 | GO:0046930 | pore complex(GO:0046930) |
0.5 | 3.2 | GO:0098554 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.5 | 2.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.5 | 3.6 | GO:0033643 | host cell part(GO:0033643) |
0.5 | 5.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.5 | 2.0 | GO:0031417 | NatC complex(GO:0031417) |
0.5 | 7.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.5 | 3.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.5 | 4.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.5 | 1.9 | GO:0045273 | respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) |
0.5 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.5 | 4.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 4.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 1.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.4 | 18.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 9.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 11.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.4 | 2.0 | GO:0000243 | commitment complex(GO:0000243) |
0.4 | 7.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 13.9 | GO:0000791 | euchromatin(GO:0000791) |
0.4 | 2.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 3.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.4 | 1.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 12.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 6.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.4 | 1.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.4 | 2.9 | GO:0032806 | holo TFIIH complex(GO:0005675) carboxy-terminal domain protein kinase complex(GO:0032806) |
0.4 | 3.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 7.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 2.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 1.0 | GO:0070826 | paraferritin complex(GO:0070826) |
0.3 | 1.6 | GO:1903767 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
0.3 | 14.6 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 9.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 2.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 392.0 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 2.8 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.3 | 37.6 | GO:0031674 | I band(GO:0031674) |
0.3 | 0.9 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
0.3 | 0.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 2.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 1.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 87.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 24.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 2.5 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 4.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.3 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 13.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 1.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 18.9 | GO:0016605 | PML body(GO:0016605) |
0.2 | 4.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 6.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 14.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 3.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 1.8 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 4.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.2 | 7.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 7.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 6.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 22.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 3.1 | GO:0019028 | viral capsid(GO:0019028) |
0.2 | 10.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 11.6 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 2.7 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 3.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 9.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 4.3 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 1.6 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 3.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 1.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 2.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 7.4 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 1.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 8.6 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 1.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 7.9 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 4.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 1.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.7 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 7.2 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 12.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 3.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 1.7 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.1 | 0.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.0 | GO:0016282 | eukaryotic 43S preinitiation complex(GO:0016282) translation preinitiation complex(GO:0070993) |
0.0 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 2.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 1.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 1.4 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.5 | 54.0 | GO:0030172 | troponin C binding(GO:0030172) |
12.2 | 61.0 | GO:0051373 | FATZ binding(GO:0051373) |
10.7 | 53.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
10.5 | 31.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
9.5 | 28.6 | GO:0008481 | sphinganine kinase activity(GO:0008481) |
9.2 | 9.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
8.4 | 50.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
8.1 | 40.4 | GO:0019862 | IgA binding(GO:0019862) |
7.2 | 50.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
7.1 | 42.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
6.5 | 19.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
6.3 | 31.6 | GO:0005550 | pheromone binding(GO:0005550) |
6.2 | 68.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
6.2 | 24.7 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
6.1 | 43.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
6.0 | 18.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
6.0 | 78.3 | GO:1990405 | protein antigen binding(GO:1990405) |
5.8 | 52.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
5.8 | 28.8 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
5.7 | 11.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
5.4 | 21.7 | GO:0031433 | telethonin binding(GO:0031433) |
5.4 | 53.9 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
5.3 | 16.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
5.3 | 42.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
5.2 | 20.6 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
4.9 | 29.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
4.9 | 34.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
4.8 | 14.4 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
4.8 | 24.0 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
4.8 | 28.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
4.7 | 14.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
4.6 | 97.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
4.4 | 35.1 | GO:0045545 | syndecan binding(GO:0045545) |
4.2 | 25.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
4.1 | 12.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
4.0 | 32.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
4.0 | 28.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
3.8 | 19.1 | GO:0031014 | troponin T binding(GO:0031014) |
3.8 | 15.2 | GO:0042806 | fucose binding(GO:0042806) |
3.7 | 15.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
3.7 | 7.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
3.6 | 18.0 | GO:0005534 | galactose binding(GO:0005534) |
3.5 | 10.5 | GO:0030984 | kininogen binding(GO:0030984) |
3.5 | 45.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
3.5 | 20.9 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
3.5 | 20.7 | GO:0035473 | lipase binding(GO:0035473) |
3.4 | 10.3 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
3.4 | 17.1 | GO:1990254 | keratin filament binding(GO:1990254) |
3.4 | 20.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
3.4 | 10.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
3.3 | 9.9 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
3.3 | 23.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
3.2 | 9.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
3.1 | 9.4 | GO:0019863 | IgE binding(GO:0019863) |
3.1 | 6.3 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
3.1 | 9.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
3.0 | 6.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
3.0 | 24.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
2.9 | 14.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
2.9 | 8.8 | GO:0051425 | PTB domain binding(GO:0051425) |
2.9 | 31.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
2.8 | 8.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
2.8 | 11.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
2.8 | 11.2 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
2.7 | 38.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
2.7 | 13.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
2.7 | 8.2 | GO:0008384 | NF-kappaB-inducing kinase activity(GO:0004704) IkappaB kinase activity(GO:0008384) |
2.7 | 35.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
2.5 | 56.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
2.4 | 7.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.4 | 7.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.4 | 9.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
2.4 | 45.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
2.4 | 16.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
2.4 | 28.5 | GO:0031432 | titin binding(GO:0031432) |
2.3 | 9.3 | GO:0008265 | Mo-molybdopterin cofactor sulfurase activity(GO:0008265) |
2.3 | 9.3 | GO:0051870 | methotrexate binding(GO:0051870) |
2.3 | 6.9 | GO:0070012 | oligopeptidase activity(GO:0070012) |
2.3 | 13.8 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
2.3 | 92.3 | GO:0070330 | aromatase activity(GO:0070330) |
2.2 | 246.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.2 | 17.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
2.1 | 6.4 | GO:0048030 | disaccharide binding(GO:0048030) |
2.1 | 6.4 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
2.1 | 16.9 | GO:0031404 | chloride ion binding(GO:0031404) |
2.1 | 8.4 | GO:0004064 | arylesterase activity(GO:0004064) |
2.1 | 8.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
2.0 | 44.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
2.0 | 6.0 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
2.0 | 8.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
2.0 | 69.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.9 | 9.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.9 | 15.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.9 | 9.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.9 | 7.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.9 | 5.6 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
1.9 | 5.6 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
1.9 | 9.4 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
1.9 | 22.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.9 | 3.7 | GO:0035673 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) oligopeptide transmembrane transporter activity(GO:0035673) |
1.8 | 38.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.8 | 36.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.8 | 7.3 | GO:0019002 | GMP binding(GO:0019002) |
1.8 | 1.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
1.8 | 3.6 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
1.8 | 5.3 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
1.8 | 5.3 | GO:0032427 | GBD domain binding(GO:0032427) |
1.7 | 34.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.7 | 10.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.7 | 10.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.7 | 12.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) |
1.7 | 6.9 | GO:0034618 | arginine binding(GO:0034618) |
1.7 | 11.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.7 | 8.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.7 | 10.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.6 | 6.5 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
1.6 | 9.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.6 | 46.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
1.6 | 346.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.6 | 14.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
1.6 | 6.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.6 | 4.8 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
1.6 | 11.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
1.5 | 38.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.5 | 6.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.5 | 6.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) hemi-methylated DNA-binding(GO:0044729) |
1.5 | 10.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.5 | 4.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
1.5 | 6.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.5 | 12.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.5 | 10.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.5 | 4.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.5 | 9.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.5 | 13.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.5 | 6.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.5 | 14.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.5 | 14.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
1.5 | 8.8 | GO:0005499 | vitamin D binding(GO:0005499) |
1.4 | 8.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.4 | 17.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.4 | 12.7 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.4 | 2.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.4 | 15.4 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.4 | 4.2 | GO:0015292 | uniporter activity(GO:0015292) |
1.4 | 4.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.4 | 4.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.3 | 5.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.3 | 26.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.3 | 11.6 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
1.3 | 10.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.3 | 8.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.2 | 3.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) leukemia inhibitory factor receptor binding(GO:0005146) |
1.2 | 7.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.2 | 4.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.2 | 4.8 | GO:0086077 | gap junction hemi-channel activity(GO:0055077) gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
1.2 | 6.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.2 | 3.6 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
1.2 | 12.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.2 | 17.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
1.2 | 15.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.2 | 5.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
1.2 | 3.5 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
1.1 | 31.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.1 | 3.4 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
1.1 | 6.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.1 | 3.4 | GO:0098603 | selenol Se-methyltransferase activity(GO:0098603) |
1.1 | 11.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.1 | 31.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
1.1 | 34.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
1.1 | 7.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.1 | 2.2 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
1.1 | 4.2 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
1.0 | 5.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.0 | 4.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.0 | 6.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
1.0 | 11.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.0 | 8.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.0 | 16.9 | GO:0003823 | antigen binding(GO:0003823) |
1.0 | 32.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.0 | 16.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
1.0 | 3.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.0 | 6.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.9 | 3.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.9 | 6.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.9 | 15.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.9 | 16.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.9 | 5.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.9 | 6.4 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.9 | 28.9 | GO:0043236 | laminin binding(GO:0043236) |
0.9 | 6.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.9 | 8.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.9 | 12.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.8 | 6.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.8 | 2.5 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.8 | 2.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 6.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.8 | 16.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.8 | 3.3 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
0.8 | 96.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.8 | 2.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.8 | 4.8 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.8 | 13.5 | GO:0005537 | mannose binding(GO:0005537) |
0.8 | 15.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.8 | 7.8 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.8 | 3.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.8 | 6.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.8 | 2.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.8 | 54.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.7 | 5.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.7 | 3.0 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.7 | 11.9 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.7 | 11.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.7 | 3.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 3.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.7 | 3.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.7 | 4.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.7 | 7.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.7 | 3.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.7 | 4.9 | GO:0034711 | inhibin binding(GO:0034711) |
0.7 | 4.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.7 | 4.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.7 | 23.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.7 | 8.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.7 | 2.0 | GO:0046592 | polyamine oxidase activity(GO:0046592) |
0.7 | 4.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.7 | 5.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.7 | 3.9 | GO:0000150 | recombinase activity(GO:0000150) |
0.6 | 26.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.6 | 7.1 | GO:0043295 | glutathione binding(GO:0043295) |
0.6 | 3.8 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.6 | 16.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.6 | 6.4 | GO:0015926 | glucosidase activity(GO:0015926) |
0.6 | 3.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.6 | 2.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.6 | 10.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.6 | 3.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) 5.8S rRNA binding(GO:1990932) |
0.6 | 13.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 9.2 | GO:0004601 | peroxidase activity(GO:0004601) |
0.6 | 1.8 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.6 | 9.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.6 | 2.4 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.6 | 2.4 | GO:0002061 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
0.6 | 4.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.6 | 6.0 | GO:0008061 | chitin binding(GO:0008061) |
0.6 | 151.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.6 | 3.6 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 142.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.6 | 5.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.6 | 9.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.6 | 3.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.6 | 59.9 | GO:0004519 | endonuclease activity(GO:0004519) |
0.6 | 3.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.6 | 2.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.6 | 14.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.5 | 1.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 1.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.5 | 1.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 3.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 6.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.5 | 8.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 2.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.5 | 1.5 | GO:0016414 | carnitine O-octanoyltransferase activity(GO:0008458) O-octanoyltransferase activity(GO:0016414) |
0.5 | 5.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.5 | 5.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.5 | 1.0 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.5 | 10.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.5 | 10.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 1.0 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.5 | 16.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.5 | 7.8 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 3.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.5 | 1.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.5 | 7.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.5 | 18.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.5 | 2.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 2.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.5 | 1.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.5 | 6.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.5 | 5.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 11.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 2.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 12.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 34.0 | GO:0035326 | enhancer binding(GO:0035326) |
0.4 | 3.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.4 | 3.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 4.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.4 | 1.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.4 | 2.5 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 3.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 1.6 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
0.4 | 3.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 4.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 1.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.4 | 5.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.4 | 2.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 20.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.4 | 1.1 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
0.4 | 7.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 3.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 28.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.3 | 9.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 16.9 | GO:0019955 | cytokine binding(GO:0019955) |
0.3 | 8.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 3.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 2.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.3 | 3.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 2.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 1.6 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.3 | 2.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 7.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.3 | 6.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 12.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 10.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 7.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 5.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 0.8 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.3 | 2.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 3.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 6.3 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 1.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 3.0 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 5.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 2.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 1.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 3.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 17.7 | GO:0020037 | heme binding(GO:0020037) |
0.3 | 18.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.3 | 4.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 2.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 28.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 11.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.3 | 8.6 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 10.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.3 | 1.3 | GO:0004586 | ornithine decarboxylase activity(GO:0004586) |
0.2 | 1.0 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 6.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 67.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 0.9 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.2 | 0.7 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 1.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.6 | GO:0017168 | 5-oxoprolinase (ATP-hydrolyzing) activity(GO:0017168) |
0.2 | 9.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 5.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 3.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 0.4 | GO:0015168 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 2.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 5.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.6 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.2 | 1.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 2.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 2.6 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.2 | 1.8 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) |
0.2 | 1.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 2.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.7 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 2.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 1.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 10.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 3.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.2 | 2.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.5 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 40.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 2.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 5.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.1 | 0.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 1.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 3.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 5.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 1.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 3.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 12.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 41.0 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 3.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 82.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 2.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 3.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 2.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.4 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 0.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 1.7 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 1.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 1.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 2.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.9 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.8 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 1.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 3.8 | GO:0005525 | GTP binding(GO:0005525) guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 1.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.0 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 84.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
4.6 | 134.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
2.8 | 66.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
2.7 | 105.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
2.7 | 106.7 | PID EPO PATHWAY | EPO signaling pathway |
2.6 | 10.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
2.5 | 50.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.5 | 126.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
2.5 | 37.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.5 | 37.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
2.2 | 93.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
2.0 | 6.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.0 | 11.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.9 | 63.7 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
1.8 | 16.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.7 | 39.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.6 | 30.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.5 | 23.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.4 | 8.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.4 | 35.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.4 | 50.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.3 | 85.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.3 | 6.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.3 | 29.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.2 | 7.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
1.2 | 26.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.2 | 18.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.2 | 52.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.0 | 4.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.0 | 37.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.0 | 29.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.0 | 26.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.9 | 10.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.9 | 31.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.9 | 16.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.9 | 18.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.9 | 15.6 | PID MYC PATHWAY | C-MYC pathway |
0.9 | 10.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.9 | 193.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.8 | 22.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.8 | 24.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.8 | 13.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.8 | 5.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 2.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.7 | 17.9 | PID ATM PATHWAY | ATM pathway |
0.7 | 11.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.7 | 9.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.6 | 22.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.6 | 28.0 | PID E2F PATHWAY | E2F transcription factor network |
0.6 | 12.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 5.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 12.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.6 | 9.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 18.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 16.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 3.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 68.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 5.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 21.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 4.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 11.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 1.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 9.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 2.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 1.3 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 10.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 10.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 4.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 11.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 5.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 3.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 2.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 3.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 4.7 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 4.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 6.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 5.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 9.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 2.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 1.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 5.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 2.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 8.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 69.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
5.1 | 55.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
3.7 | 44.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
3.6 | 36.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
3.4 | 170.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
3.3 | 9.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
3.1 | 34.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
2.9 | 29.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.9 | 46.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
2.9 | 108.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.4 | 47.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
2.3 | 43.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
2.3 | 50.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
2.2 | 52.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.9 | 16.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.8 | 49.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.8 | 17.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.7 | 32.3 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
1.7 | 46.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.6 | 8.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.6 | 67.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.5 | 7.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.4 | 17.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.4 | 14.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.4 | 16.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.3 | 38.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.3 | 10.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.3 | 13.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
1.3 | 11.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.3 | 41.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.2 | 6.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.2 | 13.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.2 | 28.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
1.2 | 43.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.1 | 16.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.1 | 15.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.1 | 13.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.1 | 5.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
1.1 | 18.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.1 | 13.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.1 | 48.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.1 | 19.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
1.1 | 6.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
1.1 | 59.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
1.1 | 7.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.1 | 4.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
1.0 | 3.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.0 | 12.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.0 | 10.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.0 | 53.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
1.0 | 11.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.0 | 12.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.9 | 41.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.9 | 35.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.9 | 6.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 12.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.8 | 11.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.8 | 6.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.8 | 12.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.8 | 20.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.8 | 7.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.8 | 13.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 50.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.7 | 23.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.7 | 7.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 16.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 14.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.7 | 23.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.6 | 27.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.6 | 6.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.6 | 25.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 11.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.6 | 2.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 8.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 19.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.5 | 2.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 3.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.5 | 5.0 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.5 | 14.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.5 | 6.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.5 | 7.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.5 | 2.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.5 | 6.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.5 | 2.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.5 | 4.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 12.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 5.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.4 | 50.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.4 | 5.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 28.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 20.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 25.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 16.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 6.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 2.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 3.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 24.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 2.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 2.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 4.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 5.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 19.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 7.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 5.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 5.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 11.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 19.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.3 | 19.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 9.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 17.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 4.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 7.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 10.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 12.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 2.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 3.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 2.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 3.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 4.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 1.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 1.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 1.9 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 2.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 2.9 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.2 | 3.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 2.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 4.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 2.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |